Lumenis M22 Laser & IPL Treatments in Maidenhead

Clinical overview

The Lumenis M22 platform allows treatment selection by indication rather than forcing all concerns into one protocol. At Berkshire Aesthetics, modules are chosen according to diagnosis, skin type, lesion behaviour and recovery tolerance. Core pathways include IPL (rejuvenation, vascular and pigmentation-focused protocols, acne and rosacea support), ResurFx non-ablative fractional laser for remodelling, Q-Switch pathways including carbon peel and selected pigment-focused protocols, plus selected tattoo removal. We plan sessions in stages with clinical review and clear aftercare.

Key Benefits

These are the main clinical and practical reasons patients choose Lumenis M22 Laser & IPL Treatments in Maidenhead. Your treatment plan is tailored after consultation rather than selected from a fixed package.

• Multi-module platform for vascular, pigment, texture and rejuvenation pathways
• Allows indication-specific protocol selection rather than generic treatment settings
• Can combine IPL, fractional and Q-Switch strategies in staged plans
• Suitable for high-volume, repeatable treatment programmes with interval review
• Useful for mixed concerns where one modality alone is insufficient

Suitable For

Suitability depends on your goals, skin or tissue characteristics, medical history, and tolerance for downtime. These criteria are reviewed in detail during your assessment.

• Patients with mixed concerns including tone, redness, texture or superficial photodamage
• Selected pigmentation and vascular indications suitable for IPL-based pathways
• Patients seeking non-ablative remodelling via ResurFx fractional laser
• Patients considering Q-Switch pathways including carbon peel and selected pigment support
• Patients seeking selected tattoo removal after proper suitability screening

Not Suitable For

Some patients should avoid or defer treatment for safety reasons. We screen carefully before any procedure and explain alternatives where relevant.

• Active skin infection or open lesions in treatment areas
• Recent significant sun exposure or inability to comply with photoprotection
• Pregnancy or breastfeeding where treatment is deferred as a precaution
• Contraindicated photosensitising medications or unmanaged dermatological disease
• Unrealistic expectations of full correction after one treatment

Final suitability is confirmed during a medical consultation and assessment.

When we don't recommend it

A consultation may identify scenarios where a different treatment route is safer or more effective for your outcome goals.

• If your concern requires a different modality with a stronger evidence-fit for your objective.
• If pigmentation risk is high and safe treatment windows cannot be met.
• If active acne or inflammatory disease needs medical control before light/laser treatment.
• If aftercare adherence is unlikely, particularly around sun avoidance.

What Happens During Treatment

We follow a consultation-first process with clear consent and aftercare. You can also review our full consultation standards.

1. 1Doctor-led consultation with diagnosis and module selection based on indication
2. 2Patch testing or preparation where clinically indicated
3. 3Treatment delivery with the selected M22 module (IPL, ResurFx or Q-Switch pathway)
4. 4Post-treatment cooling and written aftercare instructions
5. 5Planned review and staged session sequencing

Downtime & Aftercare

Recovery guidance helps protect your result and reduce avoidable complications. We provide written aftercare and safety-net advice at every appointment.

• Downtime varies by module, from minimal redness to several days of visible recovery
• Transient darkening of pigment and mild swelling can occur in selected pathways
• Strict SPF 50 and trigger control are required for reliable outcomes
• Avoid irritant actives until skin barrier recovery is complete
• Promptly report unexpected blistering, prolonged swelling or worsening discomfort

Results Timeline

Most treatments improve in stages rather than immediately. Timelines vary by treatment type, treatment area, and individual response.

• Early changes may be seen after initial sessions depending on pathway.
• Most indications require a course for cumulative improvement.
• Review intervals are commonly 3-8 weeks depending on module and response.

Individual results vary. View our results and photography standards

Risks & Side Effects

Every medical treatment carries potential risks. We discuss these in plain language before treatment so you can make an informed decision.

Common, Usually Temporary

• •Temporary redness, warmth and mild swelling
• •Short-term darkening or flaking in pigment pathways
• •Temporary sensitivity or dryness

Frequently Asked Questions

These answers cover common practical questions. If you need individual advice, please book a medical consultation.